Showing results (81-90 of 124) with videos related to
Sort By:
Pageof 13
Metabolism: Clinical and Experimental|March 31, 2005
Improvement of liver function parameters in patients with type 2 diabetes treated with thiazolidinedionesMasaya Ono, Hiroshi Ikegami, Tomomi Fujisawa, et al.British Journal of Cancer|September 4, 2021
Anthracycline-containing regimens or taxane versus S-1 as first-line chemotherapy for metastatic breast cancerHirofumi Mukai, Yukari Uemura, Hiromitsu Akabane, et al.Diabetes|November 25, 2005
Genetic heterogeneity in association of the SUMO4 M55V variant with susceptibility to type 1 diabetesShinsuke Noso, Hiroshi Ikegami, Tomomi Fujisawa, et al.Diabetes|December 29, 2006
Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resinMisato Kobayashi, Hiroshi Ikegami, Tomomi Fujisawa, et al.Breast Cancer (Tokyo, Japan)|February 9, 2019
Pharmacogenomic-pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancerHiroshi Ishiguro, Shinji Ohno, Yutaka Yamamoto, et al.Breast Cancer (Tokyo, Japan)|May 13, 2020
The efficacy of sequential second-line endocrine therapies (ETs) in postmenopausal estrogen receptor-positive and HER2-negative metastatic breast cancer patients with lower sensitivity to initial ETsTakayuki Iwamoto, Tomomi Fujisawa, Tadahiko Shien, et al.Japanese Journal of Clinical Oncology|August 7, 2015
Intensive vs. Standard Post-Operative Surveillance in High-Risk Breast Cancer Patients (INSPIRE): Japan Clinical Oncology Group Study JCOG1204Takashi Hojo, Norikazu Masuda, Tomonori Mizutani, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 16, 2010
Association of gene polymorphism of the fat-mass and obesity-associated gene with insulin resistance in JapaneseIzumi Shimaoka, Kei Kamide, Mitsuru Ohishi, et al.Plos One|November 29, 2022
Health-related quality of life and estimation of the minimally important difference in the Functional Assessment of Cancer Therapy-Endocrine Symptom score in postmenopausal ER+/HER2- metastatic breast cancer with low sensitivity to endocrine therapyYuichiro Kikawa, Yasuhiro Hagiwara, Tomomi Fujisawa, et al.Japanese Journal of Clinical Oncology|July 1, 2026
De-escalation of breast surgery for early stage breast cancerTakeshi Murata, Tomomi Fujisawa, Fumikata Hara, et al.Pageof 13